Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional

ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease

ClinicalTrials.gov ID: NCT07850063

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07850063. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 20, 2026, 2:38 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-centre, Randomised, Double-blind, Placebo-controlled, Phase IIIb Trial to Evaluate the Effect of Survodutide on Cardiac Structure and Function of Participants With Overweight or Obesity and Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD); (ELEVATE-LIVER)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is for adults aged 18 years and older who have a type of fatty liver disease called metabolic dysfunction-associated steatotic liver disease (MASLD). People can take part if their body mass index (BMI) is 27 kg/m² or higher, and they have certain heart and blood vessel risk factors. The purpose of this study is to find out how a medicine called survodutide affects heart structure and function in people with MASLD. Participants are put into 2 groups randomly, which means by chance. One group gets survodutide as an injection under the skin of the abdomen once a week. The other group gets placebo as an injection once a week. Placebo looks like survodutide but does not contain any medicine. The first injection is given at the study site. Later injections are usually given by the participants themselves at home using pre-filled syringes. Participants and doctors do not know who is getting survodutide or placebo. Participants are in the study for up to 1.5 years. During this time, they visit the study site about 14 times and have about 4 phone calls with the study staff. At some of the visits, doctors use ultrasound scans to check the heart. The results are compared between the 2 groups to see if survodutide helps improve the health of the heart. The study staff also regularly check participants' health and take note of any health problems.

Study identification

NCT ID
NCT07850063
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
600 participants

Conditions and interventions

Interventions

Combination Product

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 25, 2026 (Estimated)
Primary completion
Apr 29, 2029 (Estimated)
Completion
Apr 29, 2029 (Estimated)
Last update posted
Nov 18, 2026

2026 – 2029

United States locations

U.S. sites
28
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
Arizona Clinical Trials - Flagstaff Liver Clinic Flagstaff Arizona 86001 —
The Institute for Liver Health II DBA Arizona Clinical Trials Peoria Arizona 85381 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
Fomat Medical Research Oxnard California 93030 —
California Liver Research Institute Pasadena California 91105 —
Interventional Cardiology Medical Group West Hills California 91307 —
Advanced Research Institute Denver Colorado 80218 —
Rocky Mountain Gastroenterology Lakewood Colorado 80228 —
Florida Research Institute Lakewood Rch Florida 34211 —
Covenant Metabolic Specialists, LLC - University Park University Park Florida 34201 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Kansas Medical Clinic PA Topeka Kansas 66606 —
Capital Digestive Care Chevy Chase Maryland 20815 —
Woodholme Gastroenterology Associates Glen Burnie Maryland 21061 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Huron Gastroenterology Associates Ypsilanti Michigan 48197 —
Washington University School of Medicine St Louis Missouri 63110 —
Southwest Gastroenterology Associates, P.C. Albuquerque New Mexico 87109 —
Duke University Medical Center Durham North Carolina 27710 —
Coastal Research Institute, LLC Fayetteville North Carolina 28304 —
Moses H. Cone Memorial Hospital Greensboro North Carolina 27401 —
Piedmont HealthCare, PA Statesville North Carolina 28625 —
Oregon Health & Sciences University Portland Oregon 97239 —
Palmetto Clinical Research Summerville South Carolina 29485 —
Internal Medicine and Pediatric Associates of Bristol, PC Bristol Tennessee 37620 —
Methodist Dallas Medical Center Dallas Texas 75203 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
Advanced Research Institute Sandy City Utah 84070 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07850063, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2026 · Synced Nov 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.